Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

In vivo pharmacodynamics of new lipopeptide MX-2401.

Craig WA, Andes DR, Stamstad T.

Antimicrob Agents Chemother. 2010 Dec;54(12):5092-8. doi: 10.1128/AAC.00238-10. Epub 2010 Sep 20.

2.

In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.

Andes D, Marchillo K, Stamstad T, Conklin R.

Antimicrob Agents Chemother. 2003 Oct;47(10):3165-9.

3.

In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model.

Andes D, Marchillo K, Stamstad T, Conklin R.

Antimicrob Agents Chemother. 2003 Apr;47(4):1193-9.

4.

In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model.

Andes D, Marchillo K, Lowther J, Bryskier A, Stamstad T, Conklin R.

Antimicrob Agents Chemother. 2003 Apr;47(4):1187-92.

5.

In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria.

van Ogtrop ML, Andes D, Stamstad TJ, Conklin B, Weiss WJ, Craig WA, Vesga O.

Antimicrob Agents Chemother. 2000 Apr;44(4):943-9.

Supplemental Content

Loading ...
Support Center